Immunomedics Develops Potential New Treatment Regimen for Non … – MarketWatch (press release)
Immunomedics Develops Potential New Treatment Regimen for Non …MarketWatch (press release)… they are combined with chemotherapy, such as rituximab + CHOP (R-CHOP) for … and rituximab + hyper-fractionated CVAD for mantle cell lymphoma (MCL).Immuno…
